Tivan Limited
Tivan Limited (TVN.AX) Financial Performance & Income Statement Overview
Review Tivan Limited (TVN.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Tivan Limited (TVN.AX) Income Statement & Financial Overview
Review Tivan Limited TVN.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $5000.00 | $0.00 |
| Cost of Revenue | $103000.00 | $363000.00 | $320000.00 | $377000.00 |
| Gross Profit | -$103000.00 | -$363000.00 | -$315000.00 | -$377000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | -$63.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.07M | $2.62M | $2.12M | $4.72M |
| Operating Expenses | $3.07M | $60.52M | $2.16M | $4.72M |
| Total Costs & Expenses | -$3.18M | $60.88M | $2.16M | $5.10M |
| Interest Income | $28000.00 | $28000.00 | $82000.00 | $58000.00 |
| Interest Expense | $128000.00 | $4.87M | $10000.00 | $5000.00 |
| Depreciation & Amortization | $103000.00 | $363000.00 | $39000.00 | $377000.00 |
| EBITDA | -$2.97M | -$60.48M | -$3.91M | -$4.66M |
| EBITDA Ratio | $0.00 | $0.00 | -$782.40 | $0.00 |
| Operating Income | -$3.18M | -$60.88M | -$2.16M | -$5.10M |
| Operating Income Ratio | $0.00 | $0.00 | -$431.40 | $0.00 |
| Other Income/Expenses (Net) | -$22000.00 | -$4.83M | -$2.08M | $53000.00 |
| Income Before Tax | -$3.20M | -$65.71M | -$2.12M | -$5.04M |
| Income Before Tax Ratio | $0.00 | $0.00 | -$424.20 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $2.00 | $0.00 |
| Net Income | -$3.20M | -$65.71M | -$2.12M | -$5.04M |
| Net Income Ratio | $0.00 | $0.00 | -$424.20 | $0.00 |
| EPS | -$0.002 | -$0.04 | -$0.001 | -$0.003 |
| Diluted EPS | -$0.002 | -$0.04 | -$0.001 | -$0.003 |
| Weighted Avg Shares Outstanding | $1.78B | $1.65B | $1.51B | $1.49B |
| Weighted Avg Shares Outstanding (Diluted) | $1.78B | $1.65B | $1.51B | $1.49B |
Over the past four quarters, Tivan Limited demonstrated steady revenue growth, increasing from $0.00 in Q4 2023 to $0.00 in Q2 2025. Operating income reached -$3.18M in Q2 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$2.97M, reflecting operational efficiency. Net income rose to -$3.20M, with EPS at -$0.002. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan